48024-4
AS gene mutations found [Identifier] in Blood or Tissue by Targeted gene mutation analysis Nominal
Active
Part Descriptions
LP62083-8 AS gene
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are rare genetic disorders in which several genes (e.g. SNRPN, UBE3A) on chromosome 15(q11-13) are deleted or unexpressed. Alterations in the PWS/AS region (15q11-13) may occur by several genetic mechanisms, including chance mutation, uniparental disomy, sporadic mutations, chromosome translocations, and gene deletions. PWS and AS are some of the first reported instances of imprinting disorders in humans. In PWS, the maternally inherited copies of genes are virtually silent due to imprinting. Only the paternal copies of the genes are expressed. Therefore, PWS results from the loss of paternal copies of this region. Alternately, AS is caused by deletion or inactivation of genes on the maternally inherited chromosome 15 while the paternal copy, which may be of normal sequence, is imprinted and therefore silenced.
Characteristic features of PWS include diminished fetal activity, obesity, hypotonia, developmental delay, short stature, hypogonadotropic hypogonadism, strabismus, and small hands and feet. AS is characterized by intellectual and developmental disability, sleep disturbance, seizures, jerky movements (especially hand-flapping), frequent laughter or smiling, and usually a happy demeanor.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia,
Prader-Willi Syndrome (PWS) and Angleman Syndrome (AS), Genomic Imprinting
LP62083-8 AS gene
The AS gene (major histocompatibility complex, class I, B) gene is located on chromosome 6p21.3. HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. [provided by RefSeq, Jul 2008] [NCBI Gene ID:3106]
Source: National Center for Biotechnology Information (NCBI) Gene
LOINC Names Get Info
- Fully-Specified Name
- AS gene mutations:
Prid: Pt: Bld/Tiss: Nom: Targeted gene mutation analysis - Long Common Name
- AS gene mutations found [Identifier] in Blood or Tissue by Targeted gene mutation analysis Nominal
- Short Name
- AS gene Mut Bld/T Mut Anl
- Display Name
- AS gene mutations found Targeted gene mutation analysis Nom (Bld/Tiss)
- Consumer Name Alpha Get Info
- AS gene mutations found, Blood or tissue specimen
Part Model Get Info
- Component
- AS gene mutations
LP452101-1
- Analyte
- AS gene mutations
LP452101-1
- Component Numerator
- AS gene mutations
LP452101-1
- Component Numerator Core
- AS gene
LP62083-8
- Component Numerator Core Suffix
- mutations
LP452208-4
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- Prid
LP6850-4
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Bld/Tiss
LP7061-7
- System Core
- Bld/Tiss
LP7061-7
- Super System
- NULL
- Scale
- Nom
LP7750-5
- Method
- Targeted gene mutation analysis
LP95475-7
Basic Attributes
- Class
- MOLPATH.MUT
- Type
- Laboratory
- First Released
- Version 2.21
- Last Updated
- Version 2.83 (NAM)
- Change Reason
- Based on LOINC Committee review (June 2016), "targeted" was added to the Component to clarify that this test is looking for a specific set of mutations as described in the LOINC User Guide under the Molecular Genetics section.
- Order vs. Observation
- Both
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Gen AS cílená mutační analýza: |
| el-GR | Greek (Greece) | Γονίδιο AS στοχευμένη ανάλυση μεταλλάξεων: Synonyms: MOLPATH MOLPATH.MUT Nom Prid Pt Αίμα Αίμα/Ιστός Γονίδιο Γονίδιο AS Ιστός Μοριακή γενετική στοχευμένη ανάλυση μεταλλάξεων |
| es-MX | Spanish (Mexico) | Análisis de mutaciones dirigidas al gen AS: |
| es-ES | Spanish (Spain) | Gen AS Analisis de mutaciones: |
| fr-FR | French (France) | AS gène mutation cible trouvée: |
| it-IT | Italian (Italy) | AS, gene analisi di mutazione mirata: Synonyms: Gene AS Genetica molecolare Mutazione genica Patologia molecolare Presenza o Identità Punto nel tempo (episodio) Sangue Sangue o Tessuto Tessuto & |
| nl-NL | Dutch (Netherlands) | AS-gen doelgerichte mutatie-analyse: Synonyms: AS gen molgen targeted |
| pl-PL | Polish (Poland) | AS gen ukierunkowana analiza mutacji: Synonyms: Analiza mutacji genu w zespole Angelmana diagnostyka molekularna Gen AS; |
| pt-BR | Portuguese (Brazil) | AS análise de mutação genética: Synonyms: Angelman syndrome; |
| ru-RU | Russian (Russian Federation) | AS ген исследование на мутацию: Synonyms: Кровь Кровь или Ткань Номинальный; |
| tr-TR | Turkish (Turkey) | AS geni Mutasyon analizi: |
| zh-CN | Chinese (China) | AS 基因 突变分析: Synonyms: Angelman 综合征; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://